Mineralocorticoid receptor antagonists offer an alternative for nonresolving CSC
- Posted on: Mar 25 2019
- Leave a response
This retrospective interventional case series examines the benefit of mineralocorticoid receptor antagonists (MRA) in patients with persistent central serous chorioretinopathy (CSC).
Source: AAO
Posted in: Uncategorized